MARS®: a futile tool in centres without active liver transplant support

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Liver international (Print)

• Publication date

  2007-02-01

• Fields of study

  Medicine, Engineering, Environmental Science

• Identifiers
  DOI 10.1111/j.1478-3231.2006.01388.xPMID 17241383
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Personal view: current role of artificial liver support devices

  2006cited by this paper
• The Molecular Adsorbent Recirculating System (MARS®) in the intensive care unit: a rescue therapy for patients with hepatic failure

  2006cited by this paper
• Fulminant Hepatic Failure Bridged to Liver Transplantation with a Molecular Adsorbent Recirculating System: A Single-Center Experience

  2006cited by this paper
• Liver transplantation in Singapore 1990-2004.

  2006cited by this paper
• Molecular Adsorbent Recirculating System (MARS) Application in Liver Failure: Clinical and Hemodepurative Results in 22 Patients

  2006cited by this paper
• Emerging Indications for Albumin Dialysis

  2005cited by this paper
• Outcome from molecular adsorbent recycling system (MARS™) liver dialysis following drug‐induced liver failure

  2005cited by this paper
• Preconditioning by extracorporeal liver support (MARS) of patients with cirrhosis and severe liver failure evaluated for living donor liver transplantation – a pilot study

  2005influential reference
• MARS preconditioning for living donor liver transplantation: panacea or placebo?

  2005cited by this paper
• AASLD position paper: The management of acute liver failure

  2005cited by this paper
• Acute liver failure: current management and future prospects.

  2005cited by this paper
• Molecular adsorbent recycling system in treating patients with acute liver failure: a bridge to liver transplantation.

  2004cited by this paper
• Molecular adsorbent recirculating system for acute and acute‐on‐chronic liver failure: A meta‐analysis

  2004cited by this paper
• Pathophysiological effects of albumin dialysis in acute‐on‐chronic liver failure: A randomized controlled study

  2004cited by this paper
• Living donor liver transplantation.

  2003cited by this paper
• Ethics and rationale of living-donor liver transplantation in Asia

  2003cited by this paper
• Economic evaluation and 1‐year survival analysis of MARS in patients with alcoholic liver disease

  2003cited by this paper
• Hypoglycemia in nondiabetic patients undergoing albumin dialysis by molecular adsorbent recirculating system

  2003cited by this paper
• Is there life in MARS?

  2002cited by this paper
• The pathophysiological basis of acute-on-chronic liver failure.

  2002cited by this paper
• Ten years of experience of liver transplantation in Singapore.

  2000cited by this paper
• Improvement of hepatorenal syndrome with extracorporeal albumin dialysis mars: Results of a prospective, randomized, controlled clinical trial

  2000cited by this paper
• Is there life on Mars?

  1999cited by this paper

• Clinical profile of patients with acute-on-chronic liver failure

  2021cites this paper
• Hybrid Extracorporeal Therapies as a Bridge to Pediatric Liver Transplantation*

  2018cites this paper
• Intensive Care Management of Pediatric Acute Liver Failure

  2017cites this paper
• Artificial Liver Treatment, When and Which One?

  2016cites this paper
• Acute kidney injury in acute on chronic liver failure

  2016cites this paper
• Pattern and profile of chronic liver disease in acute on chronic liver failure

  2015cites this paper
• Experience with molecular adsorbent recirculating system treatment in 20 children listed for high‐urgency liver transplantation

  2015cites this paper
• Liver dialysis in acute-on-chronic liver failure: current and future perspectives

  2014cites this paper
• High-Volume Hemofiltration in Children With Acute Liver Failure*

  2014cites this paper
• Association of Hepatitis B Virus Mutations of A1846T and C1913A/G With Acute-on-Chronic Liver Failure Development From Different Underlying Chronic Liver Diseases

  2013cites this paper
• Acute on chronic liver failure: From pathophysiology to clinical management

  2013cites this paper
• Liver transplantation in acute-on-chronic liver failure patients with high model for end-stage liver disease (MELD) scores: a single center experience of 100 consecutive cases.

  2013cites this paper
• Artificial liver support devices as treatment option for liver failure.

  2012cites this paper
• Liver support devices

  2012cites this paper
• Chapter 97C – Liver transplantation in patients with fulminant hepatitis

  2012cites this paper
• Sistemas de soporte hepático extracorpóreo Extracorporeal liver Support Systems

  2012cites this paper
• Sistemas de soporte hepático extracorpóreo

  2011cites this paper
• Extracorporeal liver support-albumin dialysis with the Molecular Adsorbent Recirculating System (MARS).

  2011cites this paper
• A CRITICAL EVALUATION OF THE MARS TREATMENT IN FINLAND

  2010influential citation
• Fulminant Hepatic Failure: Treatment

  2010cites this paper
• Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)

  2009cites this paper
• Alternative pathway therapy for hyperammonemia in liver failure

  2009cites this paper
• Artificial liver support system in acute liver failure patients waiting liver transplantation.

  2009cites this paper
• Efficacy of high-flow dialysate continuous hemodiafiltration in the treatment of fulminant hepatic failure.

  2009cites this paper
• Survival predictors in patients treated with a molecular adsorbent recirculating system.

  2009cites this paper
• Acetaminophen hepatotoxicity and acute liver failure.

  2009cites this paper
• [Usefulness and safety of extracorporeal liver support therapy using MARSR for patients with liver failure: a preliminary report].

  2009cites this paper
• Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014

  2009cites this paper
• Hepatic assist devices: Will they ever be successful?

  2009cites this paper
• Albumin Dialysis MARS: Knowledge from 10 Years of Clinical Investigation

  2009cites this paper
• Results of treatment of acute liver failure patients with use of the prometheus FPSA system.

  2009cites this paper
• Liver support devices

  2008cites this paper
• Mars and Prometheus: our clinical experience in acute chronic liver failure.

  2008cites this paper
• Prognostic factors in patients with acute liver failure undergoing live donor liver transplantation.

  2008cites this paper
• The effect of molecular adsorbent recirculating system treatment on survival, native liver recovery, and need for liver transplantation in acute liver failure patients *

  2008cites this paper
• Albumin dialysis: an update

  2007cites this paper
• MARS and the failing liver—Any help from the outer space?

  2007cites this paper